272 related articles for article (PubMed ID: 34965942)
1. From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.
Choueiri TK; Albiges L; Atkins MB; Bakouny Z; Bratslavsky G; Braun DA; Haas NB; Haanen JBAG; Hakimi AA; Jewett MAS; Jonasch E; Kaelin WG; Kapur P; Labaki C; Lewis B; McDermott DF; Pal SK; Pels K; Poteat S; Powles T; Rathmell WK; Rini BI; Signoretti S; Tannir NM; Uzzo RG; Hammers HJ
Clin Cancer Res; 2022 Mar; 28(5):831-839. PubMed ID: 34965942
[TBL] [Abstract][Full Text] [Related]
2. Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.
Choueiri TK; Atkins MB; Bakouny Z; Carlo MI; Drake CG; Jonasch E; Kapur P; Lewis B; Linehan WM; Mitchell MJ; Pal SK; Pels K; Poteat S; Rathmell WK; Rini BI; Signoretti S; Tannir N; Uzzo R; Wood CG; Hammers HJ
J Natl Cancer Inst; 2021 Mar; 113(3):234-243. PubMed ID: 32359162
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of renal cell carcinoma.
Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
[TBL] [Abstract][Full Text] [Related]
4. Update on Biomarkers in Renal Cell Carcinoma.
Saliby RM; Saad E; Kashima S; Schoenfeld DA; Braun DA
Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430734. PubMed ID: 38207251
[TBL] [Abstract][Full Text] [Related]
5. Current and Future Biomarkers in the Management of Renal Cell Carcinoma.
Reese S; Calderon L; Khaleel S; Hakimi AA
Urol Clin North Am; 2023 Feb; 50(1):151-159. PubMed ID: 36424079
[TBL] [Abstract][Full Text] [Related]
6. The genomics of renal cell carcinoma and its role in renal mass biopsy.
Salami SS; George AK; Udager AM
Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
[TBL] [Abstract][Full Text] [Related]
7. Genomics of renal cell cancer: the biology behind and the therapy ahead.
Jones J; Libermann TA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and Predictive Factors in Metastatic Renal Cell Carcinoma: Current Perspective and a Look Into the Future.
Gan CL; Dudani S; Heng DYC
Cancer J; 2020; 26(5):365-375. PubMed ID: 32947304
[TBL] [Abstract][Full Text] [Related]
9. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky G; Mendhiratta N; Daneshvar M; Brugarolas J; Ball MW; Metwalli A; Nathanson KL; Pierorazio PM; Boris RS; Singer EA; Carlo MI; Daly MB; Henske EP; Hyatt C; Middleton L; Morris G; Jeong A; Narayan V; Rathmell WK; Vaishampayan U; Lee BH; Battle D; Hall MJ; Hafez K; Jewett MAS; Karamboulas C; Pal SK; Hakimi AA; Kutikov A; Iliopoulos O; Linehan WM; Jonasch E; Srinivasan R; Shuch B
Cancer; 2021 Nov; 127(21):3957-3966. PubMed ID: 34343338
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma.
DiNatale RG; Sanchez A; Hakimi AA; Reznik E
Urol Oncol; 2020 Oct; 38(10):755-762. PubMed ID: 31155438
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine from the renal cancer genome.
Riazalhosseini Y; Lathrop M
Nat Rev Nephrol; 2016 Nov; 12(11):655-666. PubMed ID: 27694978
[TBL] [Abstract][Full Text] [Related]
12. Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
Atkins MB; Bukowski RM; Escudier BJ; Figlin RA; Hudes GH; Kaelin WG; Linehan WM; McDermott DF; Mier JW; Pedrosa I; Rini BI; Signoretti S; Sosman JA; Teh BT; Wood CG; Zurita AJ; King L
Cancer; 2009 May; 115(10 Suppl):2247-51. PubMed ID: 19402064
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Management of Hereditary Renal Cell Cancer.
Menko FH; Maher ER
Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
[TBL] [Abstract][Full Text] [Related]
14. Genomics and epigenomics of renal cell carcinoma.
Maher ER
Semin Cancer Biol; 2013 Feb; 23(1):10-7. PubMed ID: 22750267
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma: current status and emerging therapies.
Nelson EC; Evans CP; Lara PN
Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
[TBL] [Abstract][Full Text] [Related]
16. Genomics and proteomics in renal cell carcinoma: diagnosis, prognosis, and treatment selection.
Jones J; Pantuck AJ
Curr Urol Rep; 2008 Jan; 9(1):9-14. PubMed ID: 18366968
[TBL] [Abstract][Full Text] [Related]
17. Cancer of the kidney.
Zweizig SL
Clin Obstet Gynecol; 2002 Sep; 45(3):884-91. PubMed ID: 12370630
[No Abstract] [Full Text] [Related]
18. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT
Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873
[TBL] [Abstract][Full Text] [Related]
19. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.
Linehan WM; Ricketts CJ
Nat Rev Urol; 2019 Sep; 16(9):539-552. PubMed ID: 31278395
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Motzer RJ; Jonasch E; Boyle S; Carlo MI; Manley B; Agarwal N; Alva A; Beckermann K; Choueiri TK; Costello BA; Derweesh IH; Desai A; George S; Gore JL; Haas N; Hancock SL; Kyriakopoulos C; Lam ET; Lau C; Lewis B; Madoff DC; McCreery B; Michaelson MD; Mortazavi A; Nandagopal L; Pierorazio PM; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Somer B; Sosman J; Dwyer MA; Motter AD
J Natl Compr Canc Netw; 2020 Sep; 18(9):1160-1170. PubMed ID: 32886895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
